Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GT267-004 vs Vancomycin and Metronidazole in CDAD
NCT00196794Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 14
01
Overview
Phase 3, randomised, double-blind trial of tolevamer potassium-sodium in Clostridioides difficile infection (CDI) (3 arms), sponsored by Sanofi. Primary endpoint: Resolution of diarrhea at Day 10. Started Apr 2005; status: completed.
02
Drugs
tolevamer potassium-sodium
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT00196794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00196794.